This 2005 report examines the issues surrounding the tenofovir trials and makes recommendations for ensuring that trials are carried out ethically and that provisions are made for dealing with the results of the trials when they are available. The report also calls for more concerted coordination and advance planning to accelerate evaluation, licensing, and access to PrEP.
Will a pill a day prevent HIV? Anticipating the results of the tenofovir “PrEP” trials
Understanding the Results of the AIDSVAX Trial
In late February 2003, the world heard preliminary results of the first large-scale human trial of a vaccine designed to prevent HIV infection. The results for the overall trial cohort were clear and disappointing. The results for a relatively small subset of trial participants are less clear, and they have sparked controversy and require further analysis. This brochure will help you understand what we do and do not know about the experimental vaccine known as AIDSVAX.
Understanding the Results of the AIDSVAX Trial (French)
In late February 2003, the world heard preliminary results of the first large-scale human trial of a vaccine designed to prevent HIV infection. The results for the overall trial cohort were clear and disappointing. The results for a relatively small subset of trial participants are less clear, and they have sparked controversy and require further analysis. This brochure will help you understand what we do and do not know about the experimental vaccine known as AIDSVAX.
Understanding the Results of the AIDSVAX Trial (Spanish)
In late February 2003, the world heard preliminary results of the first large-scale human trial of a vaccine designed to prevent HIV infection. The results for the overall trial cohort were clear and disappointing. The results for a relatively small subset of trial participants are less clear, and they have sparked controversy and require further analysis. This brochure will help you understand what we do and do not know about the experimental vaccine known as AIDSVAX.
Antiretroviral Treatment for Prevention of HIV and Tuberculosis
Despite considerable evidence supporting the use of antiretroviral therapy (ART) for prevention of HIV and TB illness, death and transmission, only 37 percent of the 35 million people living with HIV were receiving it in 2013. This paper examines ongoing and planned global treatment as prevention studies and addresses research questions related to access and implementation.
Facing Questions about Hormonal Contraceptives and HIV: What’s next in getting answers?
In this webinar we learned about and discussed proposed research to directly evaluate how different family planning methods might impact HIV risk.
Trial designs are actively being discussed and funding is being sought for such research—but there are many questions where advocates’ voices are needed: What should a trial look like? How can method mix (the range of available family planning options) be expanded for all women? What can be done to better integrate HIV and family planning in the meantime?
View the full webinar here
Ongoing and Planned PrEP Demonstration and Implementation Studies
This is a summary table of ongoing and planned global PrEP evaluation studies.
Global Investment in HIV Cure Research and Development in 2012
In 2013 the International AIDS Society HIV Cure Resource Tracking group joined with the HIV Vaccines and Microbicides Tracking Working Group to estimate global investments in HIV cure research and produce this short report.
Rectal Microbicides Video Facilitator’s Guide
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video. Background information on rectal microbicide research and the clinical trial process is included in the guide.
Rectal Microbicides Video Facilitator’s Guide (Spanish)
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Spanish. Background information on rectal microbicide research and the clinical trial process is included in the guide.